Wilmington PharmaTech Names Kent Payne as MD and Board Member
October 27, 2025
Wilmington PharmaTech, a U.S.-based specialty contract research, development and manufacturing organization (CRDMO) focused on complex custom small molecule API, announced the appointment of Kent Payne,
